PH25928A - Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole and other heterocyclic side chains - Google Patents

Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole and other heterocyclic side chains

Info

Publication number
PH25928A
PH25928A PH37013A PH37013A PH25928A PH 25928 A PH25928 A PH 25928A PH 37013 A PH37013 A PH 37013A PH 37013 A PH37013 A PH 37013A PH 25928 A PH25928 A PH 25928A
Authority
PH
Philippines
Prior art keywords
preparation
benzothiazole
processes
side chains
intermediates
Prior art date
Application number
PH37013A
Other languages
English (en)
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH25928A publication Critical patent/PH25928A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
PH37013A 1987-06-09 1988-06-06 Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole and other heterocyclic side chains PH25928A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5989987A 1987-06-09 1987-06-09

Publications (1)

Publication Number Publication Date
PH25928A true PH25928A (en) 1991-12-19

Family

ID=22026001

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37013A PH25928A (en) 1987-06-09 1988-06-06 Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole and other heterocyclic side chains

Country Status (26)

Country Link
EP (1) EP0295051B1 (fr)
JP (1) JPH0676391B2 (fr)
KR (1) KR900004698B1 (fr)
CN (1) CN1024347C (fr)
AT (1) ATE90347T1 (fr)
AU (1) AU593742B2 (fr)
CA (1) CA1321791C (fr)
CS (1) CS274628B2 (fr)
DD (3) DD280323A5 (fr)
DE (1) DE3881583T2 (fr)
DK (1) DK309988A (fr)
EG (1) EG18613A (fr)
ES (1) ES2040853T3 (fr)
FI (1) FI93835C (fr)
HU (1) HU205108B (fr)
IE (1) IE61499B1 (fr)
IL (1) IL86660A0 (fr)
MY (1) MY103573A (fr)
NO (1) NO176317C (fr)
NZ (1) NZ224937A (fr)
PH (1) PH25928A (fr)
PL (1) PL157690B1 (fr)
PT (1) PT87669B (fr)
SU (1) SU1678208A3 (fr)
YU (1) YU46696B (fr)
ZA (1) ZA884075B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322153A3 (fr) * 1987-12-21 1990-08-16 Pfizer Inc. Acides hétérocyclyl oxophtalazinyl acétiques
WO1989006651A1 (fr) * 1988-01-19 1989-07-27 Pfizer Inc. Acides 1h-indazole-3-acetiques servant d'inhibiteurs d'aldose reductase
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
US5304557A (en) * 1989-12-15 1994-04-19 Pfizer Inc. Substituted oxoophthalazinyl acetic acids and analogs thereof
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels
WO1992003432A1 (fr) * 1990-08-28 1992-03-05 Pfizer Inc. Monohydrate d'acide 3-(5-trifluoromethylbenzothiazol-2-ylmethyle)-4-oxo-3h-phytalazine-1-ylacetique
CA2107104A1 (fr) * 1991-03-28 1992-09-29 Banavara L. Mylari Acides pyridazinoneacetiques utilises comme inhibiteurs de l'aldose reductase
FR2682108B1 (fr) * 1991-10-07 1994-01-07 Lipha Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
EP0652213B1 (fr) * 1993-10-06 1997-08-27 SUMIKA FINE CHEMICALS Co., Ltd. Procédé de préparation de alkyle 3-phtalidenylideneacetate
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (fr) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorphe du monohydrate de zopolrestat
SG82702A1 (en) * 1999-09-28 2001-08-21 Ebauchesfabrik Eta Ag Timepiece including a movement mounted in a casing ring
CN116970317B (zh) * 2023-03-20 2024-06-25 安徽庆丰涂料科技有限公司 可呼吸的负离子抗菌涂料及其加工工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
JPS5931509B2 (ja) * 1979-06-06 1984-08-02 昭和電工株式会社 ３−ヒドロキシ−３−メチルフタリド又はその核置換体の製造法
IL80475A (en) * 1985-11-07 1993-01-31 Pfizer Heterocyclic-substituted 4-oxo (or thio)-3h- phthalazinyl-acetic acid derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0295051B1 (fr) 1993-06-09
YU111188A (en) 1989-12-31
NO176317C (no) 1995-03-15
NZ224937A (en) 1991-01-29
JPS643173A (en) 1989-01-06
FI93835B (fi) 1995-02-28
EG18613A (en) 1993-08-30
DK309988D0 (da) 1988-06-08
IL86660A0 (en) 1988-11-30
DE3881583D1 (de) 1993-07-15
NO176317B (no) 1994-12-05
DK309988A (da) 1988-12-10
ATE90347T1 (de) 1993-06-15
CN88103507A (zh) 1988-12-28
AU1749188A (en) 1988-12-15
KR900004698B1 (ko) 1990-07-02
FI882722A (fi) 1988-12-10
DE3881583T2 (de) 1993-09-16
FI882722A0 (fi) 1988-06-08
DD281600A5 (de) 1990-08-15
IE881716L (en) 1988-12-09
NO882516L (no) 1988-12-12
YU46696B (sh) 1994-04-05
EP0295051A3 (en) 1989-03-22
DD280320A5 (de) 1990-07-04
ES2040853T3 (es) 1993-11-01
EP0295051A2 (fr) 1988-12-14
PL157690B1 (en) 1992-06-30
DD280323A5 (de) 1990-07-04
FI93835C (fi) 1995-06-12
MY103573A (en) 1993-08-28
KR890000476A (ko) 1989-03-14
CS392488A2 (en) 1990-08-14
HU205108B (en) 1992-03-30
ZA884075B (en) 1990-02-28
NO882516D0 (no) 1988-06-08
IE61499B1 (en) 1994-11-02
PT87669A (pt) 1988-07-01
CN1024347C (zh) 1994-04-27
PT87669B (pt) 1992-09-30
CA1321791C (fr) 1993-08-31
CS274628B2 (en) 1991-09-15
AU593742B2 (en) 1990-02-15
PL272899A1 (en) 1989-07-10
SU1678208A3 (ru) 1991-09-15
JPH0676391B2 (ja) 1994-09-28

Similar Documents

Publication Publication Date Title
PH25928A (en) Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole and other heterocyclic side chains
HUT43115A (en) Process for production of /s/-alpha-methil-aryl acetic acids
DE3064657D1 (en) Process for the co-production of carboxylic acids and carboxylic acid esters
AU4815885A (en) Enzymatic process
GB8719886D0 (en) Carboxylic acid esters/acids
AU2070683A (en) Process for the production of carboxylic acid esters and/or carboxylic acids
EP0246603A3 (en) 4-halogeno-2-oxyimino-3-oxobutyric acids
AU605754B2 (en) Process for acylating amines with 2-benzothiazolyl thioesters of carboxylic acids
ZA868121B (en) Process for the enzymatic separation of the optical isomers of 2-aminobutanol
ZA885968B (en) A process for the enzymatic preparation of optically active phosphorus-containing functional acetic acid derivatives
EP0334598A3 (fr) Synthèse d'acides 2-(4'aminophénoxy)-alcanoiques et esters et leurs dérivés
EP0397048A3 (fr) Procédé de préparation de l'acide 2-mercapto-4-méthyl-1,3-thiazol-5-yl acétique et de ses esters
AU1011488A (en) The production of carboxylic acids and esters thereof
CS274704B2 (en) Method of 4-alkoxy-3-pyrroline-2-on-1-yl acetic acid's alkyl esters production
ZA837351B (en) Process for the production of carboxylic acid esters and/or carboxylic acids
AU7867291A (en) Process for manufacture of organic esters of strong acids
HRP930557A2 (en) Process for the preparation of quinoline carboxylic acids and their intermediates